269 related articles for article (PubMed ID: 21168697)
1. Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report.
Châtelet V; Lobbedez T; Frémeaux-Bacchi V; Ficheux M; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2010 Dec; 42(10):4353-5. PubMed ID: 21168697
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
[TBL] [Abstract][Full Text] [Related]
3. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.
Zimmerhackl LB; Hofer J; Cortina G; Mark W; Würzner R; Jungraithmayr TC; Khursigara G; Kliche KO; Radauer W
N Engl J Med; 2010 May; 362(18):1746-8. PubMed ID: 20445192
[No Abstract] [Full Text] [Related]
5. Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.
Larrea CF; Cofan F; Oppenheimer F; Campistol JM; Escolar G; Lozano M
Transplantation; 2010 Apr; 89(7):903-4. PubMed ID: 20386298
[No Abstract] [Full Text] [Related]
6. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
[TBL] [Abstract][Full Text] [Related]
7. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A
Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335
[TBL] [Abstract][Full Text] [Related]
8. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
[TBL] [Abstract][Full Text] [Related]
9. Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome.
Chatelet V; Frémeaux-Bacchi V; Lobbedez T; Ficheux M; Hurault de Ligny B
Am J Transplant; 2009 Nov; 9(11):2644-5. PubMed ID: 19775316
[No Abstract] [Full Text] [Related]
10. Eculizumab for atypical hemolytic-uremic syndrome.
Nürnberger J; Philipp T; Witzke O; Opazo Saez A; Vester U; Baba HA; Kribben A; Zimmerhackl LB; Janecke AR; Nagel M; Kirschfink M
N Engl J Med; 2009 Jan; 360(5):542-4. PubMed ID: 19179328
[No Abstract] [Full Text] [Related]
11. [Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].
Latzke AB; Fernández P; Chiurchiu C; Sarmantano D; De Arteaga J; Douthat W; De la Fuente J
Medicina (B Aires); 2018; 78(2):119-122. PubMed ID: 29659362
[TBL] [Abstract][Full Text] [Related]
12. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
Nester CM; Brophy PD
Curr Opin Pediatr; 2013 Apr; 25(2):225-31. PubMed ID: 23486421
[TBL] [Abstract][Full Text] [Related]
13. Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants.
Ariceta G; Arrizabalaga B; Aguirre M; Morteruel E; Lopez-Trascasa M
Am J Kidney Dis; 2012 May; 59(5):707-10. PubMed ID: 22196848
[TBL] [Abstract][Full Text] [Related]
14. Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.
Fakhouri F; Frémeaux-Bacchi V; Loirat C
Eur J Intern Med; 2013 Sep; 24(6):492-5. PubMed ID: 23756030
[TBL] [Abstract][Full Text] [Related]
15. Prevention of recurrence of atypical hemolytic uremic syndrome post renal transplant with the use of higher-dose eculizumab
.
Riddell A; Goodship T; Bingham C
Clin Nephrol; 2016 Oct; 86(10):200-2. PubMed ID: 27616760
[TBL] [Abstract][Full Text] [Related]
16. [Eculizumab for the treatment of atypical hemolytic uremic syndrome: case report and revision of the literature].
Vaisbich MH; Henriques Ldos S; Watanabe A; Pereira LM; Metran CC; Malheiros DA; Modanez F; Silva JD; Vieira S; Macedo AC; Massarope B; Furusawa EA; Schvartsman BG
J Bras Nefrol; 2013; 35(3):237-41. PubMed ID: 24100744
[TBL] [Abstract][Full Text] [Related]
17. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
Köse O; Zimmerhackl LB; Jungraithmayr T; Mache C; Nürnberger J
Semin Thromb Hemost; 2010 Sep; 36(6):669-72. PubMed ID: 20865644
[TBL] [Abstract][Full Text] [Related]
18. Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
Levi C; Frémeaux-Bacchi V; Zuber J; Rabant M; Devriese M; Snanoudj R; Scemla A; Amrouche L; Mejean A; Legendre C; Sberro-Soussan R
Transplantation; 2017 Dec; 101(12):2924-2930. PubMed ID: 28858176
[TBL] [Abstract][Full Text] [Related]
19. Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation.
Noris M; Remuzzi G
Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):704-12. PubMed ID: 24076560
[TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
Okumi M; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():9-13. PubMed ID: 26988663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
